Login / Signup

QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study.

Lorenzo GuglielmettiSimon TiberiMatthew BurmanHeinke KunstChristian Morberg WejseTamar TogonidzeGraham BothamleyChristoph Langenull nullnull null
Published in: The European respiratory journal (2018)
Keyphrases
  • mycobacterium tuberculosis
  • drug induced
  • pulmonary tuberculosis
  • hiv aids
  • oxidative stress
  • left ventricular
  • emergency department
  • heart failure
  • adverse drug
  • atrial fibrillation
  • network analysis